NIBSC offered to explain the quality control difficulties to a representative of Bayer. Linked evidence BAYP0000001_119 - Letter from R D Andrews to J M Boult - 07 May 1976 Chronology Information Date: 1 May 1976 Chapter/issue Blood Products and Addressing Risk: Regulation of Commercial Factor Concentrates